CalciMedica, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 34.36 million compared to USD 7.82 million a year ago. Basic loss per share from continuing operations was USD 7.66 compared to USD 111.16 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.16 USD | -4.09% | -4.97% | +80.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.42% | 55.42M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.32% | 21.58B | |
-11.28% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- CALC Stock
- News CalciMedica, Inc.
- CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023